Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
FDA
Sep 16, 2023, 18:50 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 4
Three weeks ago, OncoDaily initiated its series on '100 Influential Women in Oncology: Key Opinion…
Sep 16, 2023, 18:02 |
Drugs
Ruben A. Mesa: Deeply excited by the Food and Drug Administration approval of Momelotinib for patients with myelofibrosis with anemia.
Quoting Ruben A. Mesa, the President of Atrium Health Levine Cancer, on X/Twitter: "Deeply excited…
Sep 15, 2023, 18:04 |
Opinion
Mark Lewis: For the moment I will NOT be using somatostatin receptor scintigraphy to routinely surveil my own or my practice's MEN1 NETs.
Mark Lewis recently shared a post by Thorvardur (Thor) R. Halfdanarson on X/Twitter. "I'm as…
Sep 11, 2023, 17:55 |
Opinion
Amanda Nickles Fader: Eight months into the worst chemo shortage in US history, we still have 15 drugs in short supply.
Quoting Amanda Nickles Fader, an Associate Professor at the Johns Hopkins Medicine Department of Gynecology…
Sep 10, 2023, 23:05 |
Blog
Elad Sharon: I am ecstatic to announce that I am joining Dana-Farber as the Clinical and Translational Director of the iTOX Service.
Quoting Elad Sharon, Medical Oncologist at Dana-Farber Cancer Institute, on X/Twitter: ''I am ecstatic to announce…
Sep 7, 2023, 19:34 |
Blog
,
Drugs
,
Insight
Shruti Patel: Tumor Board Tuesday - Mini tweetorial.
Shruti Patel, Oncology Fellow at Stanford Health Care, recently tweeted: "Tumor Board Tuesday - Mini…
Sep 2, 2023, 00:07 |
Insight
Nizar Jacques Bahlis: Thrilled to share our work Nature Medicine, led by the very talented Holly Lee, with Dr Paola Neri, Francesco Maura, Leo Rasche, Jonathan Keats.
Nizar Jacques Bahlis, associate professor at the Arnie Charbonneau Cancer Institute, Cumming School of Medicine,…
Aug 19, 2023, 19:19 |
Opinion
Armen Asatryan: "Accelerated Approval". This is, in my experience, probably one of the biggest misnomers in the United States pharma regulatory world.
Quoting Armen Asatryan, Founder & CEO, iClinDev Consulting on LinkedIn: " 'Accelerated Approval'. This is,…
Aug 16, 2023, 18:20 |
Opinion
James Coyne: The article provides a summary of my thinking about a seriously flawed study that gave false hope to breast cancer patients.
Quoting from a recent LinkedIn post by James Coyne, Emeritus Professor of Psychology in Psychiatry…
Aug 16, 2023, 18:18 |
Blog
Roupen Odabashian: Three Important Things They Don't Teach in Medical School.
In a LinkedIn post, Roupen Odabashian, Hematology/Oncology Fellow at the Karmanos Cancer Institute, wrote: ''Three…
92
93
94
95
96
All:
952
Posts:
931 - 940
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Vivek Subbiah: Key publications leading to Nobel Prize 2024, published in 1993
Dr. Zainab Shinkafi-Bagudu: Advocating for Equity in Cancer Care - UICC Presidential Candidacy
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube